(Q36137934)

12 August 2017

1 reference

title

The efficacy of ergogenic agents in athletic competition. Part II: Other performance-enhancing agents (English)

1 reference

12 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1591427

12 October 2022

author name string

D. A. Smith

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1591427

12 October 2022

P. J. Perry

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1591427

12 October 2022

language of work or name

English

0 references

publication date

1 May 1992

1 reference

full work available at URL

12 August 2017

http://www.theannals.com/cgi/content/abstract/26/5/653

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1591427

Annals of Pharmacotherapy

12 October 2022

published in

1 reference

12 August 2017

volume

26

1 reference

12 August 2017

issue

5

1 reference

12 August 2017

page(s)

653-659

1 reference

Growth hormone and athletes

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600510

Synthetic Human Growth Hormone: A Call for Federal Control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600510

Muscle performance in rats, normal and treated with growth hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600510

Amphetamine sulfate and athletic performance. I. Objective effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600510

Effects of dextroamphetamine on psychomotor skills

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600510

Cardiovascular and subjective effects of intravenous cocaine administration in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600510

Cocaine: clinical pharmacology and toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600510

Psychiatric side effects attributed to phenylpropanolamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600510

Muscle glycogen synthesis before and after exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600510

Blood doping--a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600510

Blood Doping: Results and Consequences From the Laboratory and the Field

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600510

Blood doping and related issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600510

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600510

10.1177/106002809202600510

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference